IL-33 Exacerbates Autoantibody-Induced Arthritis

Rheumatoid arthritis pathogenesis comprises dysregulation in both innate and adaptive immunity. There is therefore intense interest in the factors that integrate these immunologic pathways in rheumatoid arthritis. In this paper, we report that IL-33, a novel member of the IL-1 family, can exacerbate anti–glucose-6-phosphate isomerase autoantibody-induced arthritis (AIA). Mice lacking ST2 (ST2−/−), the IL-33 receptor α-chain, developed attenuated AIA and reduced expression of articular proinflammatory cytokines. Conversely, treatment of wild-type mice with rIL-33 significantly exacerbated AIA and markedly enhanced proinflammatory cytokine production. However, IL-33 failed to increase the severity of the disease in mast cell-deficient or ST2−/− mice. Furthermore, mast cells from wild-type, but not ST2−/−, mice restored the ability of ST2−/− recipients to mount an IL-33–mediated exacerbation of AIA. IL-33 also enhanced autoantibody-mediated mast cell degranulation in vitro and in synovial tissue in vivo. Together these results demonstrate that IL-33 can enhance autoantibody-mediated articular inflammation via promoting mast cell degranulation and proinflammatory cytokine production. Because IL-33 is derived predominantly from synovial fibroblasts, this finding provides a novel mechanism whereby a host tissue-derived cytokine can regulate effector adaptive immune response via enhancing innate cellular activation in inflammatory arthritis.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0902685PMID 20139274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

  2009cited by this paper
• Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

  2009cited by this paper
• Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

  2009cited by this paper
• The cytokine interleukin-33 mediates anaphylactic shock

  2009cited by this paper
• Sphingosine Kinase1 Is Pivotal for FcεRI-Mediated Mast Cell Signaling and Functional Responses In Vitro and In Vivo

  2009cited by this paper
• The master switch: the role of mast cells in autoimmunity and tolerance.

  2008cited by this paper
• Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

  2008cited by this paper
• IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice

  2008cited by this paper
• The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

  2008cited by this paper
• IL-33 induced Ag-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4

  2008cited by this paper
• IL-33 exacerbates antigen-induced arthritis by activating mast cells

  2008cited by this paper
• IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-41

  2008cited by this paper
• IL-33 reduces the development of atherosclerosis

  2008cited by this paper
• IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

  2008cited by this paper
• Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1

  2007cited by this paper
• Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.

  2007cited by this paper
• Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis

  2007cited by this paper
• IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex

  2007cited by this paper
• Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1

  2007cited by this paper
• IL-33 can promote survival, adhesion and cytokine production in human mast cells

  2007cited by this paper
• Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis

  2007cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

  2007cited by this paper
• Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy

  2007cited by this paper
• IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

  2007cited by this paper
• Cytokines in the pathogenesis of rheumatoid arthritis

  2007cited by this paper
• The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.

  2006cited by this paper
• B-cell targeting in rheumatoid arthritis and other autoimmune diseases

  2006cited by this paper
• Neutrophil-derived leukotriene B4 is required for inflammatory arthritis

  2006cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

  2004cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST21

  2004cited by this paper
• High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis

  2003cited by this paper
• Arthritis critically dependent on innate immune system players.

  2002cited by this paper
• The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis.

  2002cited by this paper
• Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

  2002cited by this paper
• Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis

  2002cited by this paper
• Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis

  2002influential reference
• The Role of FcγR Signaling in the K/B × N Serum Transfer Model of Arthritis1

  2002cited by this paper
• The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.

  1998cited by this paper
• Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

  1998cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

  1996cited by this paper
• Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.

  1995cited by this paper
• Antibodies to type II collagen in early rheumatoid arthritis.

  1993cited by this paper
• Mast cells at sites of cartilage erosion in the rheumatoid joint.

  1984cited by this paper
• Serum transfer of collagen-induced arthritis in mice

  1983cited by this paper
• RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION

  1981cited by this paper
• Decreased neutrophils and megakaryocytes in anemic mice of genotype W/Wv

  1969cited by this paper

• ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche

  2025cites this paper
• Are s.IL33 and sST2 related to the clinical and musculoskeletal ultrasound findings of systemic sclerosis arthropathy?

  2025cites this paper
• IL-33/ST2 induces Tfh cells activation and GCs formation in collagen-induced arthritis

  2025cites this paper
• Acute and prolonged effects of interleukin-33 on cytokines in human cord blood-derived mast cells.

  2024cites this paper
• The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis

  2024cites this paper
• The multifaceted role of mast cells in the pathogenesis of rheumatoid arthritis.

  2023cites this paper
• Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases

  2023cites this paper
• Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis.

  2023cites this paper
• IL-31 and IL-33 in rheumatoid arthritis patients

  2022cites this paper
• IL-33 in autoimmunity; possible therapeutic target.

  2022cites this paper
• Signaling and functions of interleukin-33 in immune regulation and diseases

  2022cites this paper
• Two major genes associated with autoimmune arthritis, Ncf1 and Fcgr2b, additively protect mice by strengthening T cell tolerance

  2022cites this paper
• IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients

  2021cites this paper
• Mast Cells as Important Regulators in Autoimmunity and Cancer Development

  2021cites this paper
• Interleukin-33 regulates metabolic reprogramming of the retinal pigment epithelium in response to immune stressors

  2021cites this paper
• Calcitriol attenuates TLR2/IL-33 signaling pathway to repress Th9 cell differentiation and potentially limits the pathophysiology of rheumatoid arthritis

  2020cites this paper
• The correlation between IL-33 and inflammation factors in rheumatoid arthritis patients in vivo and in fibroblast-like synoviocytes in vitro

  2020cites this paper
• Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice

  2020cites this paper
• Association between IL-33 and other inflammatory factors in patients with rheumatoid arthritis and in fibroblast-like synoviocytes in vitro.

  2020cites this paper
• Rheumatoid arthritis (RA) is a chronic and refractory auto‐ immune joint disease, characterized by the proliferation of synoviocytes in inflamed synovia and the expression of inflammatory cytokines and chemokines in synoviocytes (1). Multiple pro‐inflammatory and inflammatory cytokines

  2020cites this paper
• Blocking Interleukin-33 Alleviates the Joint Inflammation and Inhibits the Development of Collagen-Induced Arthritis in Mice

  2020cites this paper
• Does interleukin‐33 level correlate with the activity of Pemphigus vulgaris?: A case‐control study

  2020cites this paper
• Dietary Short-Term Fiber Interventions in Arthritis Patients Increase Systemic SCFA Levels and Regulate Inflammation

  2020cites this paper
• Calcitriol attenuates TLR2/IL-33 signaling pathway to repress Th9 cell differentiation and potentially limits the pathophysiology of rheumatoid arthritis

  2020cites this paper
• Interleukin (IL)‐33: an orchestrator of immunity from host defence to tissue homeostasis

  2020cites this paper
• Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model

  2020cites this paper
• Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia

  2020cites this paper
• The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?

  2019cites this paper
• Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages

  2019cites this paper
• Roles of mast cells in rheumatoid arthritis

  2019cites this paper
• IL-33 in Tumor Immunity: Nothing to Sneeze At.

  2018cites this paper
• Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis

  2018cites this paper
• Tranilast inhibits interleukin‐33 production by macrophages

  2018cites this paper
• Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production

  2018cites this paper
• Interleukin-33, a Potential Cytokine Expressed in the Tumor Microenvironment Is Involved in Antitumor Immunotherapy Through Facilitating CD8+ T Cells

  2018cites this paper
• DETECÇÃO DE IL‐33 SÉRICA NA ARTRITE REUMATOIDE: ASSOCIAÇÃO NEGATIVA COM SÍNDROME METABÓLICA

  2017cites this paper
• MAST CELL ACTIVATION BY DIVERSE STIMULI CAN BE SUPPRESSED BY STEROID THERAPY AND TARGETING THE FYN-STAT5B CASCADE

  2017cites this paper
• Mini-review Mast cells in collagen diseases

  2017cites this paper
• A review on interleukins: The key manipulators in rheumatoid arthritis

  2017influential citation
• Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets

  2017cites this paper
• Interleukin-33 as a marker of disease activity in rheumatoid factor positive polyarticular juvenile idiopathic arthritis

  2017cites this paper
• FRI0115 Ever-smoking is associated with disease severity and opioid use in rheumatoid arthritis

  2017influential citation
• IL‐33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice

  2017cites this paper
• FRI0114 Allograft inflammatory factor 1 (AIF1) polymorphisms RS4711274 (G/A) and RS2269475 (C/T) may predict etanercept plus methotrexate response in french caucasian patients with rheumatoid arthritis

  2017influential citation
• Study of interleukin 33 in rheumatoid arthritis versus osteoarthritis patients

  2017cites this paper
• L 33 in rheumatoid arthritis : potential contribution o pathogenesis afaela

  2016cites this paper
• Ação da IL33 na artrite reumatoide: contribuição para a fisiopatalogia

  2016cites this paper
• ACTIVATION OF HUMAN MAST CELLS TO DOWN- REGULATE MONOCYTE-MEDIATED IMMUNE RESPONSES Chapter 6

  2016cites this paper
• Dexamethasone rapidly suppresses IL‐33‐stimulated mast cell function by blocking transcription factor activity

  2016cites this paper
• Interleukin-33 Prevents Retinal Ischemia Reperfusion Injury in Rats by Preventing Apoptosis

  2016cites this paper
• Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis

  2016cites this paper
• Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

  2016cites this paper
• IL-33 and Thymic Stromal Lymphopoietin in mast cell functions.

  2016cites this paper
• Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.

  2016cites this paper
• IL33 in rheumatoid arthritis: potential contribution to pathogenesis.

  2016cites this paper
• Mast cells control insulitis and increase Treg cells to confer protection against STZ‐induced type 1 diabetes in mice

  2015cites this paper
• Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.

  2015influential citation
• Elevated interleukin‐33 and soluble ST2 levels in the sera of patients with pemphigus vulgaris: correlation with clinical and immunological parameters during follow‐up

  2015cites this paper
• Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective

  2015cites this paper
• Running title : Cytokines in Aortic Adventitia of RA patients

  2015cites this paper
• IL-33 Exacerbates Periodontal Disease through Induction of RANKL

  2015cites this paper
• The Interleukin 33/ST2 Axis in Patients with Primary Sjögren Syndrome: Expression in Serum and Salivary Glands, and the Clinical Association

  2015cites this paper
• IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

  2015cites this paper
• The role of IL-33/ST2L signals in the immune cells.

  2015cites this paper
• IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.

  2015cites this paper
• Emerging roles of IL-33 in inflammation and immune regulation

  2015cites this paper
• IL-33 and ST2 in innate and adaptive airway inflammation

  2015cites this paper
• THU0157 Serum Levels of Interleukin 33 and its Soluble Receptor ST2 are not Related to Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

  2015cites this paper
• Does Novel IL-33 Correlates with TNF-α in RA and SLE ?

  2015cites this paper
• Ability of Interleukin‐33– and Immune Complex–Triggered Activation of Human Mast Cells to Down‐Regulate Monocyte‐Mediated Immune Responses

  2015cites this paper
• Elevated IL-33 and sST2 levels in sera of patients with pemphigus vulgaris. Correlation with clinical and immunological parameters during follow up. Running head: IL-33 and sST2 in pemphigus vulgaris. Authors

  2015cites this paper
• Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies

  2014cites this paper
• IL-33/ST2 axis promotes mast cell survival via BCLXL

  2014cites this paper
• Interleukin-33: A Multifunctional Alarmin that Promotes Both Health and Disease

  2014cites this paper
• IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells

  2014cites this paper
• IL-33 attenuates the development of experimental autoimmune uveitis

  2014cites this paper
• Regulatory T Cells + To Selectively Expand IL-33 R / ST 2 Stimulates IL-2 Secretion by Dendritic Cells IL-33 Is an Unconventional Alarmin

  2014cites this paper
• IL-21 Receptor Expression in Human Tendinopathy

  2014cites this paper
• Relationship between Mast Cells and Autoimmune

  2014cites this paper
• Relationship between Mast Cells and Autoimmune Diseases

  2014cites this paper
• + To Selectively Expand IL-33R/ST2 Stimulates IL-2 Secretion by Dendritic Cells IL-33 Is an Unconventional Alarmin That

  2014cites this paper
• NUCLEAR FUNCTION AND RELEASE OF IL-33

  2014cites this paper
• Emerging role of interleukin‐33 in autoimmune diseases

  2014cites this paper
• Innate-type and acquired-type allergy regulated by IL-33.

  2014cites this paper
• IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

  2013cites this paper
• IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.

  2013cites this paper
• The IL-33/ST2 Pathway Controls Coxsackievirus B5–Induced Experimental Pancreatitis

  2013cites this paper
• A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis

  2013cites this paper
• Interleukin-33 Synergistically Enhances Immune Complex-Induced Tumor Necrosis Factor Alpha and Interleukin-8 Production in Cultured Human Synovium-Derived Mast Cells

  2013cites this paper
• Mast cell involvement in rheumatoid arthritis.

  2013cites this paper
• Interleukin-33(IL-33) in Iraqi's Rheumatoid Arthritis Patients Prone to Atherosclerosis

  2013cites this paper
• Targeting interleukin-33 in rheumatoid arthritis

  2013cites this paper
• Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency

  2013influential citation
• A Novel Interleukin 33/ST2 Signaling Regulates Inflammatory Response in Human Corneal Epithelium

  2013cites this paper
• F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation

  2012cites this paper
• New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

  2012influential citation
• Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

  2012cites this paper
• Mast Cells Respond to Cell Injury through the Recognition of IL-33

  2012cites this paper
• IL‐33 attenuates development and perpetuation of chronic intestinal inflammation

  2012cites this paper
• The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.

  2012cites this paper